Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy

Breast Journal

Volumn 19, Issue 4, 2013, Pages 365-373

  Vicini, Frank A ^a   Shaitelman, Simona ^b   Wilkinson, John Ben ^c   Shah, Chirag ^d   Ye, Hong ^e   Kestin, Larry L ^a   Goldstein, Neal S ^f   Chen, Peter Y ^e   Martinez, Alvaro A ^a  

^a 21ST CENTURY ONCOLOGY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Willis Knighton Health System   (United States)

^d SUMMA HEALTH SYSTEM   (United States)

^e OAKLAND UNIVERSITY   (United States)

^f Advanced Diagnostics Laboratory   (United States)

Author keywords

breast neoplasms; breast conserving therapy; DCIS; radiation therapy; young age

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST BIOPSY; CALCIFICATION; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CAUSE SPECIFIC SURVIVAL; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; RADIATION DOSE; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

BREAST NEOPLASMS; BREAST-CONSERVING THERAPY; DCIS; RADIATION THERAPY; YOUNG AGE;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84879725536     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/tbj.12127     Document Type: Article

References (27)

1. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C,. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275: 913-8.
2. Winchester DJ, Menck HR, Winchester DR, et al,. National treatment trends for ductal carcinoma in-situ of the breast. Arch Surg 1997; 132: 660-5.
3. Bornstein BA, Recht A, Connolly JL, et al,. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 1991; 67: 7-13.
4. Fisher B, Dignam J, Wolmark N, et al,. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol 1998; 16: 441-52.
5. Fowble B, Hanlon AL, Fein DA, et al,. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997; 38: 949-57.
6. Fourquet A, Zafrani B, Clough K, et al,. Institut Curie Experience. In:, Silverstein MJ, ed. Ductal Carcinoma In Situ of the Breast. 2nd edn. Baltimore, MD: Williams and Wilkins, 2002; 367-72.
7. Goldstein NS, Lacerna MD, Vicini FA,. The significance of cancerization of lobules and atypical ductal hyperplasia adjacent to duct carcinoma in situ of the breast with regards to breast conserving therapy. Am J Clin Pathol 1998; 110: 357-67.
8. Hiramatsu H, Bornstein BA, Recht A, et al,. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ. Possible importance of family history. Cancer J Sci Am 1995; 1: 55-61.
9. Collins LC, Achacoso N, Nekhlyudov L, et al,. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol 2009; 33: 1802-8.
10. McCormick B, Rosen PP, Kinne D, Cox L, Yahalom J,. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21: 289-92.
11. Bijker N, Meijnen P, Peterse JL, et al,. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of EORTC Randomized Phase III-A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006; 24: 3381-7.
12. Solin LJ, McCormick B, Recht A, et al,. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am 1996; 2: 158-65.
13. Solin LJ, Kurtz J, Fourquet A, et al,. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14: 754-63.
14. Alvarado R, Lari SA, Roses RE, et al,. Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol 2012; 19: 3777-84.
15. Nixon AJ, Neuberg D, Hayes DF, et al,. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994; 12: 888-94.
16. Elkhuizen PHM, van de Vijver MJ, Herman J, et al,. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998; 40: 859-67.
17. Kestin LL, Goldstein NS, Lacerna MD, et al,. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy. Cancer 2000; 88: 596-607.
18. Vicini FA, Goldstein NS, Pass H, Baglan KL, Pettinga JE, Martinez AA,. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Surg Oncol 2001; 76: 245-54.
19. Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR,. Breast relapse following primary radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1985; 11: 1271-6.
20. Fisher E, Constantino J, Fisher B, Palekar AS, Redmond C, Mamounas E,. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75: 1310-9.
21. Fisher B, Costantino J, Redmond C, et al,. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. New Engl J Med 1993; 328: 1581-6.
22. Silverstein MJ, Lagios MD, Martino S, et al,. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16: 1367-73.
23. Vicini FA, Eberlein TJ, Connolly JL, et al,. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991; 214: 200-4.
24. Hwang E, Samli B, Tran K, Rosen PP, Borgen PI, Van Zee KJ,. Volume of resection in patients treated with breast conservation for ductal carcinoma in situ. Ann Surg Oncol 1998; 5: 757-63.
25. Holland P, Gandhi A, Knox WF, Wilson M, Baildam AD, Bundred NJ,. The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer 1998; 77: 110-4.
26. Jhingran A, Kim JS, Buchholz TA, et al,. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: the University of Texas M.D. Anderson Cancer Center Experience. Int J Radiat Oncol Biol Phys 2002; 54: 804-9.
27. Tumon-de-Lara C, Andre G, MacGrogan G, et al,. Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients. Ann Surg Oncol 2011; 18: 1372-9.